Testing an enema along with lifestyle changes to improve fatty liver disease.

Comparative Evaluation Of Patoladi Gana Niruha Basti As An Adjuvant To Lifestyle Modification In Grade 2 NAFLD Using Hepatic Enzymes And Cytokeratin 18 Biomarker - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106130

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Grade 2 NAFLD confirmed by USG, Elevated liver enzymes (ALT,AST) above normal range, Cytokeratin 18.

Exclusion criteria

Exclusion criteria: Basti Anarha, Patients having major illness like Insulin dependent DM, Cardiac Illness, Untreated thyroid, Pregnancy, Lactation, Grade 3 NAFLD, Cirrhosis, Hepatitis, or other chronic liver diseases, History of alcohol consumption, Alcoholic.

Design outcomes

Primary

Measure	Time frame
To evaluate changes in Hepatic enzyme profileTimepoint: Baseline and 8th day	—

Secondary

Measure	Time frame
To evaluate changes in Cytokeratin 18(CK 18)levels in both groupsTimepoint: Baseline and 21st day	—

Countries

India

Contacts

Public ContactDr Vishnu U

Amrita Viswavidyapeetham

pillaidrvishnu@gmail.com9567198958

Outcome results